The World Health Organization releases updated guidelines and a new operational handbook on TB care and support to improve the quality of life and better outcomes for people with TB.

The Global Plan to End TB 2023-2030 outlines the priority actions and estimated financial resources needed to end TB as a global health threat by 2030.

Communities affected by TB everywhere have a right to benefit from scientific progress, including access to short-course, bedaquiline-based treatment regimens for drug-resistant TB.

The Global TB Caucus releases an analysis examining the region’s laws on public health, health systems, labor, TB, and other infectious diseases.

The updated WHO consolidated guidelines on treatment of drug-susceptible TB include a new recommendation for the use of a 4-month regimen composed of isoniazid, rifapentine, moxifloxacin and pyrazinamid.

The brochure provides a brief overview of up-to-date prevention, diagnosis, and treatment of TB based on human rights, high ethical standards, and a people-centered approach.

A report highlights stories from people living with HIV and TB in Ukraine to demonstrate the need for an ambitious pledge at the Global Fund's upcoming Seventh Replenishment in September 2022.

Words Matter for people affected by TB: Call for everyone to champion empowering language free from stigma and discrimination.

New Digital TB Surveillance System Report on 19 countries.

While TB kills more people each year than HIV/AIDS and malaria combined, more money is allocated to HIV and malaria than to TB in the new Global Fund strategy.